Increase in mucormycosis hospitalizations in southeastern Brazil during the COVID-19 pandemic: a 2010-2021 time series.
Rev Soc Bras Med Trop
; 56: e0333, 2023.
Article
in English
| MEDLINE | ID: covidwho-2257531
ABSTRACT
BACKGROUND:
Mucormycosis is a severe invasive fungal disease. During the coronavirus disease 2019 (COVID-19) pandemic, outbreaks have been reported worldwide, but epidemiological studies are still scarce in Brazil.METHODS:
We conducted a time-series cohort hospitalization study (2010-2021) in southeastern Brazil.RESULTS:
There were 311 cases (85 during the pandemic), with significant (P < 0.05) involvement of patients older than 40 years (84%), white patients (78%), rhinocerebral site (63%), and São Paulo State residents (84%).CONCLUSIONS:
Mucormycosis hospitalizations were highly prevalent. Further studies are needed to assess the burden of COVID-19 on mucormycosis in Brazil.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Mucormycosis
Type of study:
Cohort study
/
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Limits:
Humans
Country/Region as subject:
South America
/
Brazil
Language:
English
Journal:
Rev Soc Bras Med Trop
Year:
2023
Document Type:
Article
Affiliation country:
0037-8682-0333-2022
Similar
MEDLINE
...
LILACS
LIS